108 Artikel
A clinical guide to interpreting microbiome and high-plex proteomic reports — what each layer actually measures, how much weight it deserves, and why convergence across independent layers is the only signal strong enough to act on.
A practical framework for sequencing advanced imaging in preventive practice: why a picture of disease outranks a score that predicts it, where coronary calcium goes blind in younger patients, and how to weigh whole-body MRI's occult cancers against its cascades.
Beherrschen Sie die modernste Wissenschaft der fibrinolytischen Dysfunktion – von der *SERPINE1*-Epigenetik und Seneszenz-Rückkopplungsschleifen bis hin zu aufkommenden PAI-1-Inhibitoren und Präzisionsprotokollen zur Wiederherstellung der Gerinnselabbaukapazität.
A clinical guide to interpreting genetic risk alongside blood biomarkers in cardiovascular prevention — why apoB beats LDL-C, where Lp(a) fits, how to catch insulin resistance a decade early, and why a laboratory reference range is not a target.
A clinical guide to what common single-nucleotide variants and curated panels genuinely deliver — pharmacogenomic phenotypes, HLA risk types, polygenic percentiles — and the structural reasons a negative panel in a symptomatic patient tells you almost nothing.
A clinical guide to reading HLA results: which alleles change prescribing today, why a coeliac-permissive type is not a diagnosis, and when a genome-derived HLA call must be confirmed before you act on it.
A clinician's guide to interpreting metabolizer phenotype labels, the gene–drug pairs with evidence strong enough to act on today, and why a genotype describes capacity rather than current enzyme activity.
A practical guide to interpreting a polygenic risk score report — how the number is built, how to convert a percentile into absolute risk, why the score may not apply to your patient at all, and why a high score usually changes timing and intensity rather than diagnosis.
A clinician's guide to reading the classification column on a genomic report: what dbSNP, gnomAD and ClinVar each contribute, why a variant of uncertain significance must never drive management, and how to explain penetrance to a patient who has just been called 'pathogenic'.
Tauchen Sie tief in die molekulare Maschinerie ein, die der Rolle von Laktat bei der Langlebigkeit zugrunde liegt – von der HCAR1-Rezeptorpharmakologie und der Laktatylierungs-Stöchiometrie bis hin zu Interorgan-Stoffwechselkreisläufen und klinischen Translationsstrategien.
A clinician's guide to the five stages between a sample and a genomic report — what each accomplishes, why millions of variants is a normal result, and how a poorly read region becomes a falsely reassuring negative.
A clinical reading guide to 30× whole genome sequencing: what the depth figure means, how it differs from a SNP array and an exome, and the specific variant classes a normal genome report does not exclude.
